Research Achievements
Kazuo Suzuki| 2012 | 2011 | 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Yasuda H‚ Suzuki K. Measures against transmission of pandemic H1N1 influenza in Japan in 2009: simulation model
Euro Surveillance 2009; 14(44) (pii=19385):
Hirahashi J‚ Hishikawa K‚ Kaname S‚ Tsuboi N‚ Stavrakis G‚ Shimosawa T‚ Xiao L‚ Nagahama Y‚ Suzuki K‚ Fujita T‚ Mayadas T N. Mac-1 (CD11b/CD18‚ CR3) is a critical molecular link between inflammation and thrombosis following glomerular injury.
Circulation 2009; 120 (13): 1255-1264
Miura N‚ Komai M‚ Adachi Y‚ Osada N‚ Kameoka Y‚ Suzuki K‚ Ohno N. Candida albicans water-soluble fraction (CAWS)‚ a mannoprotein-IL-10 Is a Negative Regulatory Factor of CAWS-Vasculitis in CBA/J Mice as Assessed by Comparison with Bruton’s Tyrosine Kinase-Deficient CBA/N Mice.
The Journal of Immunology 2009; 183 (5): 3417-3424
Nozu T‚ Kondo M‚ Suzuki K‚ Tamaoki J‚ Nagai A. A Comparison of the Clinical Features of ANCA-Positive and ANCA-Negative Idiopathic Pulmonary Fibrosis Patients.
Respiration 2009; 77 407-415
Kaga C‚ Nomura S‚ Okochi M‚ Nozu T‚ Nagao T‚ Nagai A‚ Nakayama T‚ Suzuk Ki‚ Honda H. Screening of epithelial cell-adhesive peptides from fibronectin loop region and its cell specificity.
J Chem. Engineering Japan 2009; 4 298-302
International Conferences
Hirahashi J‚ Kuwahara K‚ Arita M‚ Nagao T‚ Suzuki K‚ Hishikawa K‚ Fujita T. Dietary enrichment with eicosapentanoic acd (EPA) prevents anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculiits.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Fujimoto S‚ Kobayashi S‚ Suzuki K. Incidence and clinical phenotype of ANCA-associated renal vasculitis: comparison between Japan and the UK.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Uno K‚ Muso E‚ Ito-Ihara T‚ Yagi K‚ Fujita S‚ Suzuki K. Comparison of plasma cytokine/chemokine levels and IFN-alpha production capacity amongst healthy subjects‚ patients with MPO-ANCA positive MPA‚ and IgA nephritis.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Tomizawa K‚ Nagao T‚ Saiga K‚ Oshima M‚ Kobayashi K‚ Nakayama T‚ Tanokura M‚ Suzuki K. Risk Epitopes of MPO-ANCA in SCG/Kj mice.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Takahashi K‚ Oharaseki T‚ Yokouchi Y‚ Yamada H‚ Mamada H‚ Naoe S‚ Saji T‚ Ohno N‚ Suzuki K. Effect of anti-TNF-alpha medicaments in mice vasculitis model caused by Candida albicans water soluble fraction.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Suzuki K‚ Tomizawa K‚ Nagao T‚ Kobayashi S‚ Muso E‚ Yumura W‚ Sasaki T‚ Hotta O‚ Harabuchi Y‚ Homma S‚ Yamanishi Y‚ Lund‚ Sweden and Copenhagen‚ DenmarkNishii M‚ Jayne D‚ Rasmussen N‚ Nakayama T‚ Hashimoto H‚ Japan-UK-EU Project Members. Risk Epitopes of MPO-ANCA in Patients with MPA in Japan.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Oharaseki T‚ Yokouchi Y‚ Wakayama M‚ Ihara F‚ Yamada H‚ Suzuki K‚ Naoe S‚ Takahashi K. Histopathology of late-stage arteritis in murine systemic vasculitis induced by polysaccharide of Candida albicans‚ as animal model of Kawasaki disease.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Muso E‚ Joh K‚ Ihara T‚ Iwasaki Y‚ Komiya T‚ Suzuki K. Specific cytokines and chemokines as the predictor of clinical and pathological activity and chronicity in patients with ANCA-ANCA-positive MPA.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Ito-Ihara T‚ Muso E‚ Kobayashi S‚ Uno K‚ Tamura N‚ Yamanishi Y‚ Fukatsu A‚ Watts R A‚ G.I. Scott D‚ R.W. Jayne D‚ Suzuki K‚ Hashimoto H. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe. Clin. Exp. Rheumatol.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Suzuki K. Lecture on Epitope of MPO-ANCA in Workshop-I: Epitope specificity.
14th International Vasculitis and ANCA Workshop 2009-6-6 Lund‚ Sweden and Copenhagen/Denmark
Furutani M‚ Kameoka Y‚ Takahashi K‚ Aratani Y‚ Nagi-Miura N‚ Ohn N‚ NagaoT‚ Suzuki K. Synthetic polyclonal immunoglobulin
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-5-14 Tokyo/Japan
Tomizawa K‚ Nagao T‚ Saiga K‚ Oshima M‚ Kobayashi K‚ Nakayama T‚ Tanokura M‚ Suzuki K. Association of risk epitopes of MPO-ANCA with renal failure in SCG/Kj mice showing crescentic glomerulonephritis.
6th International Human Peroxidase Meeting 2009-4-19 Chapel Hill‚ North Carolina/U.S.A.
Suzuki K‚ Hamano Y. Role of the ‘Man-1’ cluster gene region on chromosome-1 in response in MPO-ANCA vasculitis genetic dissection of vasculitis‚ MPO-ANCA production‚ and related traits in scg/kj mice.
6th International Human Peroxidase Meeting 2009-4-19 Chapel Hill‚ North Carolina/U.S.A.
Suzuki K. Myeloperoxidase and the heart
Myeloperoxidase and the heart’ 6th International Human Peroxidase Meeting 2009-4-19 Chapel Hill‚ North Carolina/U.S.A.
Suzuki K. Clinical pictures and risk parameters of avian influenza (H5N1) infection in Vietnam
Infectious Diseases Workshop Modeling 2009-3-9 Murramarang/Australia
Maehara Y‚ Kawachi S‚ Nagao T‚ Todaka R‚ Jun Z‚ Oshima M‚ Suzuki K. Cytokines and chemokines in the early phase of mice ventilator-induced lung injury model in mice
2009 International Anesthesia Research Society Annual Meeting 2009-3-14 San Diego/U.S.A.
Suzuki K. Preparedness for the spread of influenza: Prohibition of Traffic‚ school closure‚ and vaccination of children in the commuter towns of Tokyo
International Symposium Infectious Diseases 2009-2-17 Tokyo/Japan
Hamano Y‚ Yumura W‚ Kusano E‚ Suzuki K. Genetic dissection of leukocytosis related to spontaneously occurring crescentic glomerulonephritis in a model of SCG/Kj mice.
The American Society of Nephrology The 42nd Annual Meeting and Scientific Exposition 2009-10-27 San Diego/U.S.A.
Hirahashi J‚ Kawahata K‚ Hishikawa K‚ Fujita T‚ Arita M‚ Nagao T‚ Suzuki K‚ Nakakuki M‚ Saiga K. Dietary enrichment with eicosapentanoic acid (EPA) prevents antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Muso E‚ et al. IVIg therapy for MPO-ANCA positive MPA-For further effort to establish the evidence in Japan-
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Ohno N‚ Suzuki K. Analysis of Cytokine Production by PBMC in Vitor Stimulated with Solid Phase IVIg
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Kameoka Y‚ Furutani M‚ Suzuki K Evaluation of variety of artificial poly-clonal γ glbulin
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Aratani Y‚ Suzuki K. Phagocyte NADPH-oxidase deficiency promotes zymosan-induced acute lung inflammation
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Uno K‚ Mso E‚ Ihara T‚ Suzuki K. Comparison of plasma cytokine/chemokine levels and IFN-αproduction capacity amongst healthy subjects‚ MPO-ANCA nephritis patients‚ and IgA nephritis patients
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Furutani M‚ Kameoka Y‚ Takahashi K‚ Aratani Y‚ Nagi-Miura N‚ Ohno N‚ Nagao T‚ Suzuki K. Synthetic polyclonal immunoglobulin
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Kobayashi S‚ Suzuki K‚ Fujimoto S New consensus‚ definition‚ classification and system for diagnosis of vasculitis from EULAR and ACR meeting held in Zurich
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Kawachi S‚ Nunoi H‚ Suzuki K. Treatment of severe ARDS (including H5N1-FARDS) with IVIg -From the Cases of NHP-Hanoi-
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Tomizawa K‚ Nagao T‚ Osahima M‚ Kobayashi K‚ Suzuki K. Decreased of Risk Epitpies of MPO-ANCA with Remission: Preliminary Analysis
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Chang He T‚ Nagao T‚ Nakayama K‚ Suzuki K. Modulation of endothelial cell functions by intravenous immunoglobulin in vitro
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
Suzuki‚ K. Immunomodulatory therapy for vasculitis with synthetic IVIG
International Forum on Inflammation-2009‚ ’IVIg treatmen and development of synthetic IgG’ 2009-1-9 Tokyo/Japan
